Hyperion Therapeutics Inc (NASDAQ:HPTX)

29.78
Delayed Data
As of Mar 03
 -0.39 / -1.29%
Today’s Change
20.23
Today|||52-Week Range
31.31
+24.08%
Year-to-Date

Today’s Trading

Previous close30.17
Today’s open29.22
Day’s range-- - --
Volume293,730
Average volume (3 months)170,391
Market cap$617.1M
Dividend yield--
Data as of 03/03/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-216.25%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales9.30
Price/Book5.01

Competitors

 Today’s
change
Today’s
% change
OSIROsiris Therapeutics ...+0.14+0.81%
FPRXFive Prime Therapeut...-1.33-5.10%
IMGNImmunoGen Inc-0.35-4.44%
AERIAerie Pharmaceutical...-0.33-1.14%
Data as of 03/03/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$0.22
Annual revenue (last year)$42.2M
Annual profit (last year)$16.6M
Net profit margin39.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Donald J. Santel
Chief Financial Officer &
Senior Vice President
Jeffrey S. Farrow
Corporate headquarters
Brisbane, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account